Athens Medical C.S.A. (ATH:IATR)

Market Cap	163.06M
Revenue (ttm)	270.92M
Net Income (ttm)	-4.73M
Shares Out	86.74M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (1.06%)
Ex-Dividend Date	n/a

Volume	5,283
Average Volume	7,097
Open	1.890
Previous Close	1.880
Day's Range	1.820 - 1.890
52-Week Range	1.470 - 2.350
Beta	0.90
RSI	39.17
Earnings Date	Dec 30, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,495
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2024, Athens Medical C.S.A.'s revenue was 269.85 million, an increase of 4.44% compared to the previous year's 258.36 million. Earnings were 1.78 million, a decrease of -77.99%.